Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 14 results.
User Information
Export Records
  1. 1.   Severe Clinical Phenotypes of Heterozygous Females With X-Linked Chronic Granulomatous Disease
  2. Patel, Niraj C; Younger, M Elizabeth M; Williams, Kelli; Matias Lopes, Joao Pedro; Kuhns,Doug; Patel, Meera N; Miranda, Mary Ann; Marciano, Beatriz E; Deal, Christin Lawler; Leiding, Jennifer W
  3. The journal of Allergy and Clinical Immunology. In Practice. 2024, Sep 25;
  1. 2.   Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV
  2. Swanstrom,Adrienne; Gorelick,Robert; Welker,Jorden; Schmidt, Fabian; Lu, Bing; Wang, Kelly; Rowe, William; Breed,Matthew; Killoran,Kristin; Kramer,Josh; Donohue,Duncan; Roser,James; Bieniasz, Paul D; Hatziioannou, Theodora; Pyle,Cathi; Thomas, James A; Trubey, Charles M; Zheng, Jim; Blair, Wade; Yant, Stephen R; Lifson,Jeffrey; Del Prete,Greg
  3. EBioMedicine. 2023, Aug 23; 95: 104764.
  1. 3.   Long-acting rilpivirine (RPV LA) pre-exposure prophylaxis does not inhibit vaginal transmission of RPV-resistant HIV-1 nor select for high frequency drug resistance in humanized mice
  2. Melody, Kevin; Roy, Chandra N; Kline, Christopher; Cottrell, Mackenzie L; Evans, Dwayne; Shutt, Kathleen; Pennings, Pleuni S; Keele,Brandon; Bility, Moses; Kashuba, Angela D M; Ambrose, Zandrea
  3. Journal of virology. 2020, APR; 94(8):
  1. 4.   Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
  2. Martinez-Navio, José M; Fuchs, Sebastian P; Mendes, Desiree E; Rakasz, Eva G; Gao, Guangping; Lifson,Jeffrey; Desrosiers, Ronald C
  3. Frontiers in immunology. 2020, MAR 17; 11: 449.
  1. 5.   Post-exposure prophylactic vaccine candidates for the treatment of human Risk Group 4 pathogen infections
  2. Logue, James; Crozier,Ian; Jahrling, Peter B; Kuhn, Jens H
  3. Expert review of vaccines. 2020, Jan 15; 19(1): 85-103.
  1. 6.   Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
  2. Houser, K. V.; Gretebeck, L.; Ying, T.; Wang, Y.; Vogel, L.; Lamirande, E. W.; Bock, K. W.; Moore, I. N.; Dimitrov, D. S.; Subbarao, K.
  3. The Journal of infectious diseases. 2016, 15-May; 213(10): 1557-61.
  1. 7.   Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice
  2. Denton, P. W.; Krisko, J. F.; Powell, D. A.; Mathias, M.; Kwak, Y. T.; Martinez-Torres, F.; Zou, W.; Payne, D. A.; Estes, J. D.; Garcia, J. V.
  3. Plos One. 2010, Jan; 5(1): 11.
  1. 8.   VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice
  2. Enterlein, S.; Warfield, K. L.; Swenson, D. L.; Stein, D. A.; Smith, J. L.; Gamble, C. S.; Kroeker, A. D.; Iversen, P. L.; Bavari, S.; Muhlberger, E.
  3. Antimicrobial Agents and Chemotherapy. 2006, Mar; 50(3): 984-993.
  1. 9.   Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies
  2. Zhu, Z. Y.; Dimitrov, A. S.; Bossart, K. N.; Crameri, G.; Bishop, K. A.; Choudhry, V.; Mungall, B. A.; Feng, Y. R.; Choudhary, A.; Zhang, M. Y.; Feng, Y.; Wang, L. F.; Xiao, X. D.; Eaton, B. T.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Virology. 2006, JAN; 80(2): 891-899.
  1. 10.   Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS
  2. Zhang, M. Y.; Choudhry, V.; Xiao, X. D.; Dimitrov, D. S.
  3. Current Opinion in Molecular Therapeutics. 2005, APR; 7(2): 151-156.
  1. 11.   Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague
  2. Powell, B. S.; Andrews, G. P.; Enama, J. T.; Jendrek, S.; Bolt, C.; Worsham, P.; Pullen, J. K.; Ribot, W.; Hines, H.; Smith, L.; Heath, D. G.; Adamovicz, J. J.
  3. Biotechnology Progress. 2005, SEP-OCT; 21(5): 1490-1510.
  1. 12.   Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis
  2. Yang, H. Y.; Rouse, J.; Lukes, L.; Lancaster, M.; Veenstra, T.; Zhou, M.; Shi, Y.; Park, Y. G.; Hunter, K.
  3. Clinical & Experimental Metastasis. 2004 21(8): 719-735.
  1. 13.   Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza - Randomized controlled trials for prevention and treatment
  2. Hayden, F. G.; Treanor, J. J.; Fritz, R. S.; Lobo, M.; Betts, R. F.; Miller, M.; Kinnersley, N.; Mills, R. G.; Ward, P.; Straus, S. E.
  3. Jama-Journal of the American Medical Association. 1999 282(13): 1240-1246.
  1. 14.   Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl) Adenine Treatment For Prevention of Persistent Simian Immunodeficiency Virus Sivmne Infection Depends Critically On Timing of Initiation and Duration of Treatment
  2. Tsai, C. C.; Emau, P.; Follis, K. E.; Beck, T. W.; Benveniste, R. E.; Bischofberger, N.; Lifson, J. D.; Morton, W. R.
  3. Journal of Virology. 1998 72(5): 4265-4273.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel